American International Group, Inc. Adaptive Biotechnologies Corp Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, American International Group, Inc. holds 55,983 shares of ADPT stock, worth $202,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,983

Previous 56,464 0.85%

Holding current value

$202,658

Previous $276,000 35.14%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.88 - $4.8 $1,385 - $2,308	-481 Reduced 0.85%	55,983 $179,000
Q4 2023 Feb 13, 2024	SELL	$3.46 - $5.33 $788 - $1,215	-228 Reduced 0.4%	56,464 $276,000
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $10,221 - $17,015	2,016 Added 3.69%	56,692 $308,000
Q2 2023 Aug 04, 2023	BUY	$6.19 - $8.78 $5,360 - $7,603	866 Added 1.61%	54,676 $366,000
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $8,353 - $10,827	1,071 Added 2.03%	53,810 $475,000

Q4 2022 Feb 10, 2023	SELL	$6.26 - $9.34 $1,195 - $1,783	-191 Reduced 0.36%	52,739 $402,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $4,855 - $9,464	747 Added 1.43%	52,930 $377,000
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $321,395 - $739,711	50,218 Added 2555.62%	52,183 $422,000
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $20 - $57	-2 Reduced 0.1%	1,965 $27,000
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $1,736 - $2,542	-69 Reduced 3.39%	1,967 $55,000
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $4,833 - $6,419	-161 Reduced 7.33%	2,036 $69,000
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $15,723 - $21,759	488 Added 28.55%	2,197 $90,000
Q1 2021 May 07, 2021	SELL	$37.26 - $67.74 $7,638 - $13,886	-205 Reduced 10.71%	1,709 $69,000
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $3,600 - $5,237	-80 Reduced 4.01%	1,914 $113,000
Q3 2020 Nov 04, 2020	BUY	$35.79 - $48.81 $1,717 - $2,342	48 Added 2.47%	1,994 $97,000
Q2 2020 Aug 12, 2020	BUY	$24.95 - $48.38 $13,822 - $26,802	554 Added 39.8%	1,946 $94,000
Q1 2020 May 04, 2020	BUY	$16.96 - $34.16 $17,706 - $35,663	1,044 Added 300.0%	1,392 $39,000
Q4 2019 Feb 05, 2020	SELL	$24.56 - $32.8 $343 - $459	-14 Reduced 3.87%	348 $10,000
Q3 2019 Nov 08, 2019	BUY	$30.31 - $53.51 $10,972 - $19,370	362 New	362 $11,000

Others Institutions Holding ADPT

# of Institutions

200

Shares Held

146M

Call Options Held

2.6K

Put Options Held

143K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $517M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Adaptive Biotechnologies Corp Transaction History